BioMerieux Income from Discontinued Operations 2017-2024 | BMXMF

BioMerieux annual/quarterly income from discontinued operations history and growth rate from 2017 to 2024. Income from discontinued operations can be defined as income or loss from the complete discontinuation of a segment or business, net of associated taxes and fees.
  • BioMerieux income from discontinued operations for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux income from discontinued operations for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • BioMerieux annual income from discontinued operations for 2024 was $0B, a 0% decline from 2023.
  • BioMerieux annual income from discontinued operations for 2023 was $0B, a 0% decline from 2022.
  • BioMerieux annual income from discontinued operations for 2022 was $0B, a 0% decline from 2021.
BioMerieux Annual Income from Discontinued Operations
(Millions of US $)
2024 $0
2023 $0
2022 $0
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $0
BioMerieux Quarterly Income from Discontinued Operations
(Millions of US $)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2022-06-30
2021-12-31
2021-06-30
2020-12-31
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $16.861B $4.307B
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $144.179B 27.04
CVS Health (CVS) United States $86.198B 10.71
Elevance Health (ELV) United States $84.314B 10.88
Cencora (COR) United States $57.484B 20.00
DiDi Global (DIDIY) China $23.485B 24.95
Natera (NTRA) United States $22.963B 0.00
Labcorp Holdings (LH) United States $21.509B 17.45
EUROFINS SCIENT (ERFSF) Luxembourg $14.205B 0.00
Solventum (SOLV) United States $12.912B 13.67
CochLear (CHEOY) Australia $12.870B 0.00
ICON (ICLR) Ireland $11.851B 11.02
Revvity (RVTY) United States $11.644B 20.04
Viatris (VTRS) United States $10.704B 3.68
Avantor (AVTR) United States $9.363B 13.60
HealthEquity (HQY) United States $9.068B 39.72
Medpace Holdings (MEDP) United States $8.818B 23.42
Sonic Healthcare (SKHHY) Australia $8.465B 0.00
Charles River Laboratories (CRL) United States $7.445B 14.59
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.269B 25.15
BrightSpring Health Services (BTSG) United States $4.058B 37.23
Sotera Health (SHC) United States $3.225B 18.32
Surgery Partners (SGRY) United States $2.781B 36.17
Alignment Healthcare (ALHC) United States $2.722B 0.00
Concentras Parent (CON) United States $2.652B 15.33
Organon (OGN) United States $2.594B 2.76
GeneDx Holdings (WGS) United States $2.556B 98.45
PACS (PACS) United States $1.958B 0.00
Ardent Health (ARDT) United States $1.904B 8.12
Progyny (PGNY) United States $1.840B 40.49
Premier (PINC) United States $1.796B 13.63
GoodRx Holdings (GDRX) United States $1.761B 35.21
Teladoc Health (TDOC) United States $1.412B 0.00
Establishment Labs Holdings (ESTA) $1.181B 0.00
Pediatrix Medical (MD) United States $1.171B 8.91
CareDx (CDNA) United States $1.074B 16.77
Agilon Health (AGL) United States $0.956B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.806B 7.54
Nutex Health (NUTX) United States $0.658B 9.96
LifeMD (LFMD) United States $0.615B 0.00
Embecta (EMBC) United States $0.542B 3.65
InnovAge Holding (INNV) United States $0.532B 0.00
Enhabit (EHAB) United States $0.482B 39.62
Auna S.A (AUNA) Luxembourg $0.470B 10.58
SBC Medicals (SBC) United States $0.464B 0.00
Omada Health (OMDA) $0.460B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
Performant Healthcare (PHLT) United States $0.312B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.249B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
So-Young (SY) China $0.209B 0.00
Oncology Institute (TOI) United States $0.200B 0.00
DocGo (DCGO) United States $0.172B 28.17
Pheton Holdings (PTHL) China $0.115B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.096B 0.00
KindlyMD (NAKA) United States $0.089B 0.00
Sera Prognostics (SERA) United States $0.075B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
ModivCare (MODV) United States $0.051B 0.00
Biodesix (BDSX) United States $0.041B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
Basel Medical Group (BMGL) Singapore $0.033B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00